Company Filing History:
14 out of 258 
3 out of 3 
1 out of 1 Years Active: 2019-2024
Title: Christopher W. Helsen: Pioneering Innovations in T Cell-Antigen Couplers
Introduction
Christopher W. Helsen is an accomplished inventor based in Oakville, CA, who has made significant contributions to the field of immunology. With a remarkable portfolio of 15 patents, he has focused his efforts on innovating T cell-antigen couplers, which hold the potential for revolutionary applications in cancer therapies and immunotherapeutics.
Latest Patents
Helsen's latest patents include groundbreaking work on "Claudin 18.2 T cell-antigen couplers and uses thereof." This patent details the creation of polypeptides that include (i) an antigen-binding domain that targets Claudin 18.2, (ii) an antigen-binding domain for a protein associated with a T cell receptor (TCR) complex, and (iii) a T cell receptor signaling domain polypeptide. Additionally, nucleic acids encoding these TACs are also delineated in this patent.
Another significant patent involves a "T cell-antigen coupler with various construct optimizations." This trifunctional molecule features (i) a target-specific ligand, (ii) a ligand that interacts with a TCR complex protein, and (iii) a T cell receptor signaling domain polypeptide. This patent discusses various molecular variants that enhance surface expression, transduction efficiency, and effector functionality, including numerous ligands that bind CD3 epsilon and different signaling domains.
Career Highlights
Throughout his career, Christopher W. Helsen has held pivotal roles in prominent institutions, notably at McMaster University and Triumvira Immunologics USA, Inc. His research and innovative work have significantly advanced the understanding of T cell interactions, leading to potentially novel treatments in the fight against cancer.
Collaborations
Helsen has collaborated with esteemed colleagues such as Jonathan Lorne Bramson and Kenneth Anthony Mwawasi. These partnerships have proven vital in driving his research forward, contributing to the development of new immunotherapeutic strategies and enhancing the effectiveness of T cell therapies.
Conclusion
In conclusion, Christopher W. Helsen stands out as a key figure in the field of immunology with his innovative inventions and numerous patents. His work on T cell-antigen couplers marks a significant milestone in cancer research and therapeutic development. With continued collaboration and further research, his contributions have the potential to lead to groundbreaking advancements in medical science.